SCHEMBL27342

SCHEMBL27342

C1CC2(C1)CCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26821 0.94
SCHEMBL14759991 0.94
SCHEMBL1443200 0.94
Hydrochloric Acid SCHEMBL30118562 0.89
SCHEMBL2788793 0.89 ALDH1A1 (0.30)
SCHEMBL16877523 0.89 ALDH1A1 (0.30)
SCHEMBL335821 0.89
SCHEMBL23914 0.88
SCHEMBL28544 0.82
SCHEMBL2238894 0.82 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2255 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010833-A Method for catalyzing tension ring heteroaryl by iron 南京师范大学 2026-05-12 CN claimed
WO-2026087634-A1 TREM2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2026-04-30 WO claimed
EP-3730590-B1 LIQUID CRYSTAL MEDIA WITH HOMEOTROPIC ALIGNMENT MERCK PATENT GMBH (DE) 2025-12-24 EP claimed
EP-4658646-A1 BENZIMIDAZOLE AND AZA-BENZIMIDAZOLE BASED IL-17A MODULATORS AND USES THEREOF Dice Alpha, Inc. (US) 2025-12-10 EP claimed
EP-4357438-B1 LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS MERCK PATENT GMBH (DE) 2025-11-26 EP claimed
EP-4648763-A2 COMPOUNDS FOR FGFRS INHIBITORS Cogent Biosciences, Inc. (US) 2025-11-19 EP claimed
EP-4646197-A2 ORGANIC COMPOUNDS AS NLRP3 INHIBITORS Kodiak Sciences Inc. (US) 2025-11-12 EP claimed
EP-4630406-A1 AMIDE COMPOUNDS AS ACTIVATORS OF THE POTASSIUM CHANNELS KV7.2/KV7.3 USEFUL IN THE TREATMENT OF CNS AND PNS DISORDERS ANGELINI PHARMA S.P.A. (IT) 2025-10-15 EP claimed
EP-4262797-B1 AMIDO-SUBSTITUTED PYRIDYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES MERCK SHARP & DOHME LLC (US) 2025-10-08 EP claimed
EP-4314194-B1 AROMATIC ISOTHIOCYANATES MERCK PATENT GMBH (DE) 2025-09-10 EP claimed
US-8022205-B2 Pyrimidine derivatives as PI3K inhibitor and use thereof CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2011-09-20 US claimed
US-20110034628-A1 BRANCHED POLYOLS CONTAINING ON AVERAGE TWO OR MORE HYDROXYL GROUPS PER MOLECULE,THEIR PREPARATION AND USE BASF COATINGS AG (DE) 2011-02-10 US claimed
WO-2010094455-A1 THIOPHENE COMPOUNDS FOR LIQUID-CRYSTALLINE MEDIA MERCK PATENT GMBH (DE) 2010-08-26 WO claimed
US-7744968-B2 Cyclobutane and spiro[3.3]heptane compounds MERCK PATENT GMBH (DE) 2010-06-29 US claimed
US-20100069629-A1 PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-03-18 US claimed
EP-2050749-A1 PYRIMIDINE DERIVATIVE AS PI3K INHIBITOR AND USE THEREOF CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-04-22 EP claimed
EP-2027174-A1 BRANCHED POLYOLS HAVING A STATISTICAL AVERAGE OF TWO OR MORE HYDROXYL GROUPS IN THE MOLECULE, PROCESS FOR THEIR PREPARATION AND USE THEREOF BASF Coatings AG (DE) 2009-02-25 EP claimed
WO-2007131674-A1 BRANCHED POLYOLS HAVING A STATISTICAL AVERAGE OF TWO OR MORE HYDROXYL GROUPS IN THE MOLECULE, PROCESS FOR THEIR PREPARATION AND USE THEREOF BASF COATINGS AG (DE) 2007-11-22 WO claimed
US-20030229084-A1 Barbituric acid derivatives as inhibitors of TNF-alpha converting enzyme (TACE) and/or matrix metalloproteinases BRISTOL-MYERS SQUIBB COMPANY 2003-12-11 US claimed
EP-0854899-B1 FLUORINE-SUBSTITUTED ALKENYL LIQUID CRYSTALLINE COMPOUNDS CHISSO CORP (JP) 2001-01-10 EP claimed